Relationship of P-value with Observed Treatment Effect Size and Its Clinical Relevancy
View Presentation *Peiling Yang, Food And Drug Administration Keywords: p-value, statistical significance, clinical relevance Statistical significance is often defined by comparing the p-value to a pre-set significance level. Assessment of clinical significance requires reliable estimates of the benefit and risk to be weighed. Clearly in order for the benefit to outweigh the risk, the benefit must be unquestionably established. We will explore through an example the relationship between the observed treatment effect size and the associated p-value, and discuss whether or not statistical significance itself may be sufficient to demonstrate efficacy even if the observed treatment effect size is small.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC